Fate Therapeutics (F6T.F) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.48
-0.42
-0.36
-0.3

Details

Expected EPS
-0.39228167115
Actual EPS
-0.37678
Surprise EPS
0.02
Surprise Percent
+3.95%

Description

Fate Therapeutics (F6T.F) has reported earnings of -0.37678 per share for Q4 2024.

0 Comments

Share your thoughts